J9176 Injection, elotuzumab, 1mg
Also known as: elotuzumab, Empliciti
Intravenous injection of elotuzumab, a monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), dosed per 1 milligram.
In Plain Language
multiple myeloma immunotherapy; natural killer cell stimulator
Clinical Context
Used for multiple myeloma in combination with lenalidomide and dexamethasone, activating natural killer cells.
RVU Information
CPT J9176 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9176?
CPT J9176 (Injection, elotuzumab, 1mg) is a J Codes (Drugs) code. Intravenous injection of elotuzumab, a monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), dosed per 1 milligram.
How is J9176 administered?
CPT J9176 is administered by a healthcare provider, typically via injection or infusion. Used for multiple myeloma in combination with lenalidomide and dexamethasone, activating natural killer cells. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9176 used?
Used for multiple myeloma in combination with lenalidomide and dexamethasone, activating natural killer cells.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.